“Demen­tia, also referred to as major neu­rocog­ni­tive dis­or­der (includ­ing Alzheimer dis­ease [AD]), is a grow­ing prob­lem because of increased lifes­pan. There is no known cure. Sev­er­al drugs are FDA-approved for the treat­ment of demen­tia, includ­ing acetyl­cholinesterase inhibitors (eg, donepezil, rivastig­mine, galan­t­a­mine) and an N-methyl-D-aspar­tate (NMDA) recep­tor antag­o­nist, but these have lim­it­ed effi­ca­cy, adverse effects, and sig­nif­i­cant cost—all of which con­tribute to the search for alter­na­tive ther­a­pies to improve cog­ni­tion.

In this arti­cle, we look at sev­er­al nat­ur­al prod­ucts used to improve cog­ni­tive impair­ment or cog­ni­tive symp­toms of dementia…The major­i­ty of tri­als that show the ben­e­fits of gink­go bilo­ba per­tain to improved cog­ni­tion in per­sons who already have a major neu­rocog­ni­tive dis­or­der or demen­tia. How­ev­er, the data regard­ing a ben­e­fit in cog­ni­tive­ly intact indi­vid­u­als are mixed. ”

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters and more, SharpBrains is an independent market research firm tracking health and performance applications of brain science.